iifl-logo

Tata Nifty MidSmall Healthcare Index Fund Dir G

Tata Nifty MidSmall Healthcare Index Fund Dir G

Fund Name

Tata Mutual Fund

Scheme Name

Tata Nifty MidSmall Healthcare Index Fund Dir G

AMC

Tata Mutual Fund

Type

:  Open

Category

Equity - Index

Launch Date

08-Apr-2024

Fund Manager

Nitin Sharma

Net Assets (Rs. cr)

207.04

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Karvy Customer: For activating your account click here.

Tata Nifty MidSmall Healthcare Index Fund Dir G - Nav Details

Nav Date

:  18-Aug-2026

NAV [Rs.]

:  15.3442

Buy/Resale Price [Rs.]

0

Sell/Repurchase Price [Rs.]

0

Entry Load %

Nil

Exit Load %

0.25% of the applicable NAV, if redeemed on or before 15 days from the date of allotment. Nil - if redeemed on or after 15 days from the date of allotment

Tata Nifty MidSmall Healthcare Index Fund Dir G- NAV Chart

Tata Nifty MidSmall Healthcare Index Fund Dir G- Performance(%)

Returns above 1 yr. are annualized

1W
1M
3M
6M
1Y
3Y
5Y
Since INC
Scheme Returns
-0.8
2.79
8.6
21.54
16.72
-
-
20.34
Category Avg
-0.84
1.43
5.55
1.32
4.22
13.8
10.78
8.2
Category Best
3.97
8.31
19.46
27.77
37.39
32.85
17.99
28.9
Category Worst
-5.08
-4.28
-8.16
-13.91
-16.9
0.6
6.51
-18.69

Tata Nifty MidSmall Healthcare Index Fund Dir G- Latest Dividends

No Records Found

Tata Nifty MidSmall Healthcare Index Fund Dir G- Investment Details

Min. Investment(Rs.)

5000

Increm.Investment(Rs.)

1000

In & Out

In

InName Of The CompanyNo Of Shares
Acutaas Chemical16,395

Out

InName Of The CompanyNo Of Shares
J B Chemicals &23,634

Fund Holdings

Asset Type
Instrument Name
Industry
Net Assets(%)
No of Shares
Mkt Value(Cr.)
Equity & Equity related Investments
EquityLaurus LabsPharmaceuticals & Biotechnology10.7912300622.34
EquityLupinPharmaceuticals & Biotechnology8.967677718.54
EquityFortis Health.Healthcare Services7.5216475115.56
EquityAurobindo PharmaPharmaceuticals & Biotechnology6.688750913.82
EquityAlkem LabPharmaceuticals & Biotechnology5.141849910.63
EquityGlenmark Pharma.Pharmaceuticals & Biotechnology5.144760210.63
EquityBioconPharmaceuticals & Biotechnology4.642255579.60
EquityMankind PharmaPharmaceuticals & Biotechnology4.27357928.83
EquityIpca Labs.Pharmaceuticals & Biotechnology3.71439157.67
EquityKrishna Institu.Healthcare Services3.19819586.59
EquityAster DM QualityHealthcare Services3.18800456.58
EquityGland PharmaPharmaceuticals & Biotechnology3.05251916.30
EquitySai LifePharmaceuticals & Biotechnology2.77436205.73
EquityNeuland Labs.Pharmaceuticals & Biotechnology2.5127265.19
EquityWockhardtPharmaceuticals & Biotechnology2.47261085.11
EquityAcutaas ChemicalPharmaceuticals & Biotechnology2.46163955.09
EquityDr Lal PathlabsHealthcare Services2.27246384.69
EquityAjanta PharmaPharmaceuticals & Biotechnology2.23133154.61
EquityAbbott IndiaPharmaceuticals & Biotechnology2.2116474.57
EquityNarayana HrudayaHealthcare Services2.14218444.43
EquityOneSource Speci.Pharmaceuticals & Biotechnology1.94248624.02
EquityPiramal PharmaPharmaceuticals & Biotechnology1.861966393.84
EquityGlobal HealthHealthcare Services1.84270713.80
EquityGranules IndiaPharmaceuticals & Biotechnology1.83458793.78
EquityGlaxosmi. PharmaPharmaceuticals & Biotechnology1.68130853.47
EquityNatco PharmaPharmaceuticals & Biotechnology1.26284042.60
EquitySyngene Intl.Healthcare Services1.12601052.31
EquityPfizerPharmaceuticals & Biotechnology1.1247902.31
EquityCohance LifePharmaceuticals & Biotechnology1.06514392.18
EquityPoly MedicureHealthcare Equipment & Supplies0.99120752.05

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Karvy Customer: For activating your account click here.

MY WEALTH AT RETIREMENT

Calculate the worth of your wealth at retirement

Key information

Fund House:
Tata Mutual Fund
Incorporation Date:
15-Mar-1994
Total Assets Managed (Cr.):
2,31,388.30
Trustee/s:
Mr. Kersi Bhagat-Associat, Tata Trustee Company Priv
Chairman:
NA
CEO / MD:
Anand Vardarajan
CIO:
NA
President:
NA
Director/s:
Mr. Gangan Rai
Compliance Officer/s:
Upesh Shah, Mr. Padmanabhan Ramanatha
Investor Service Officer/s:
NA
Fund Manager/s:
Nitin Sharma
Auditors:
NA

OTHER INFORMATION

Registered Office:
1903, B-Wing, Parinee Crescenzo, G-Block, Bandra Kurla Complex, Bandra East Mumbai - 400051
Contact Nos:
022 62827777
Fax:
022 2261 3782.
Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2026, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132 (Member ID - NSE: 10975 BSE: 179 MCX: 55995 NCDEX: 01249), DP SEBI Reg. No. IN-DP-185-2016, PMS SEBI Regn. No: INP000002213, IA SEBI Regn. No: INA000000623, Merchant Banker SEBI Regn. No. INM000010940, RA SEBI Regn. No: INH000000248, BSE Enlistment Number (RA): 5016, AMFI-Registered Mutual Fund Distributor & SIF Distributor
ARN NO : 47791 (Date of initial registration – 17/02/2007; Current validity of ARN – 08/02/2027), PFRDA Reg. No. PoP 20092018, IRDAI Corporate Agent (Composite) : CA1099

ISO certification icon
We are ISO/IEC 27001:2022 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.